Hub Cures Bi-weekly Speakers Series
Tuesdays 5 PM April 27-July 13
HUB CURES hosts bi-weekly speakers in the lead-up to MALSI+ 2021, the Commonwealth’s flagship networking event for life sciences startups and innovation. Join with scientific innovators, entrepreneurs, business leaders and investors in this engaging series spotlighting how Massachusetts universities are leading the nation in bringing translation science to market.
All Events are virtual on Tuesday evenings. General Schedule:
Todd Golub is director of the Broad Institute of MIT and Harvard, and a founding core member and director of the Gerstner Center for Cancer Diagnostics. He is a member of the faculty of the Dana-Farber Cancer Institute and Harvard Medical School and a world leader in creating and applying tools of genomics to understand the basis of cancer. Full Bio
Dale C. Van Demark, partner at McDermott, Will & Emery works at the forefront of strategic transactions, AI and digital health matters in the health, life sciences and technology industries. Full Bio
July 8: Catherine Klapperich and Peter H. Reinhart on Lessons from COVID-19 Testing
Catherine Klapperich is Director of the NIBIB POCTRN Center for Future Technologies in Cancer Care (CFTCC) at Boston University, and Director of the Laboratory for Diagnostics and Global Healthcare Technologies. Her research focuses on engineering medical devices for use in low-resource settings and at the point of care. Full Bio
Peter H. Reinhart is Founding Director, Institute for Applied Life Sciences, University of Massachusetts Amherst. He has more than 20 years of R&D management experience in the neuroscience and orphan disease space. He has led drug discovery programs in academia, biotechnology, and large Pharma. Full bio
Jeffrey Karp is Brigham and Women’s Hospital Distinguished Chair in Clinical Anesthesiology, Perioperative and Pain Medicine, and Professor of Anesthesia at Harvard Medical School in Boston. He works in the fields of drug delivery, medical devices, stem cell therapeutics, and tissue adhesives; and is additionally on the faculty at the Harvard Stem Cell Institute, the Broad Institute, and at the Harvard-MIT Division of Health Sciences and Technology. Full Bio
Kim Lewis is University Distinguished Professor of Biology at Northeastern University, and a leader in antibiotic discovery. He is renowned for discovering compounds that kill persister cells responsible for chronic infections, an antibiotic with no detectable resistance, and a novel class of antibiotics acting against problematic Gram-negative pathogens. Full Bio
Nabiha Saklayen co-founded Cellino Biotech, a personalized regenerative medicine company that is developing an AI-guided laser editing platform for autologous cell-based therapies--making these therapies scalable for the first time. The startup recently raised a $16M seed round led by The Engine and Khosla Ventures. Full Bio
Curtis R. Carlson, Ph.D., is a pioneer in the development and use of innovation best practices and an evangelist for innovation, education, and economic development, sharing best practices with government agencies, businesses, and foundations around the world. See his Bio
MALSI + 2021 Sponsors
Platinum: MassBio, Novo Nordisk
Gold: Bayer; Massachusetts Life Science Center; McDermott, Will & Emery; Troutman Pepper
Silver: Burns Levinson, Goldcast
Supporter: Boston Entrepreneur's Network, Eli Lilly & Company, Explora Biolabs, Johnson & Johnson Innovation
